MagicMed Industries Closes Oversubscribed Private Placement for $1,642,880 with Mackie Research Capital Corporation Sep 2 • 4 min read MagicMed Industries Inc. announced that it has completed its brokered private placement for gross proceeds of $1,642,880.
Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder Sep 2 • 5 min read Revive Therapeutics Ltd. announced that they have entered into a Clinical Trial Agreement with the University of Wisconsin System for a study on the effectiveness of psilocybin in treating methamphetamine use disorder.
Better Plant Sciences Adds eCommerce Sales of 200 Plant-Based Products Through Agreement with JUSU Sep 1 • 6 min read Better Plant Sciences Inc. announced that they have taken over the day-to-day sales of Jusu Life and Jusu Body products.
Mindset Pharma Announces Promising Test Results of its Novel and Proprietary Psilocybin-Inspired Compounds Aug 31 • 3 min read Mindset Pharma announced the preliminary screening results of certain synthesized compounds.
Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence Aug 28 • 7 min read Champignon Brands Inc. will offer esketamine for the treatment of adults with major depressive disorder starting in September 2020.